1.1 Articolo in rivista

1.1 Articolo in rivista: [27856] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 24.481 a 24.500 di 27.856

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.

2009-01-01 Mantovani, A; Sica, A; Allavena, P; Garlanda, C; Locati, M.

Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.

2010-01-01 Lech, M; Skuginna, V; Kulkarni, Op; Gong, J; Wei, T; Stark, Rw; Garlanda, C; Mantovani, A; Anders, Hj.

Serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and pentraxin 3 (PTX3) as markers of infection in febrile patients with systemic lupus erythematosus.

2009-01-01 Kim, J; Koh, Jk; Lee, Ey; Park, Ja; Kim, Ha; Lee, Eb; Garlanda, C; Cotena, A; Song, Yw.

Evolution of the pentraxin family: the new entry PTX4.

2010-01-01 Martinez de la Torre, Y; Fabbri, M; Jaillon, S; Bastone, A; Nebuloni, M; Vecchi, A; Mantovani, A; Garlanda, C

The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa.

2011-01-01 Moalli, F; Paroni, M; Véliz Rodriguez, T; Riva, F; Polentarutti, N; Bottazzi, B; Valentino, S; Mantero, S; Nebuloni, M; Mantovani, A; Bragonzi, A; Garlanda, C

Pentraxins and atherosclerosis: the role of PTX3.

2011-01-01 Garlanda, C; Bottazzi, B; Moalli, F; Deban, L; Molla, F; Latini, R; Mantovani, A

The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.

2010-01-01 Norata, Gd; Garlanda, C; Catapano, Al

Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus.

2011-01-01 Lech, M; Römmele, C; Kulkarni, Op; Susanti, He; Migliorini, A; Garlanda, C; Mantovani, A; Anders, Hj.

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

2012-01-01 Stefanini, G. G.; Byrne, R. A.; Serruys, P. W.; de Waha, A; Meier, B; Massberg, S; Jüni, P; Schömig, A; Windecker, S; Kastrati, A.

Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques.

2012-01-01 Räber, L; Heo, J. H.; Radu, M. D.; Garcia-Garcia, H. M.; Stefanini, G. G.; Moschovitis, A; Dijkstra, J; Kelbaek, H.; Windecker, S; Serruys, P. W.

The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial

2011-01-01 Stefanini, G. G.; Serruys, P. W.; Silber, S; Khattab, A. A.; van Geuns, R. J.; Richardt, G; Buszman, Pe; Kelbæk, H; van Boven, Aj; Hofma, S. H.; Linke, A; Klauss, V; Wijns, W; Macaya, C; Garot, P; Di Mario, C; Manoharan, G; Kornowski, R; Ischinger, T; Bartorelli, A. L.; Gobbens, P; Windecker, S.

A prospective study to evaluate the accuracy of pulse power analysis to monitor cardiac output in critically ill patients

2008-01-01 Cecconi, M; Jayne, Fawcett; Robert Michael, Grounds; Andrew, Rhodes

Treatment strategy for colorectal cancer with resectable synchronous liver metastases: Is any evidence-based strategy possible?

2012-01-01 Vigano', L

Fat-absorptiom and gastroenteric pH profile in postsurgical pancreatic insufficiency: Role of the association of H2-receptor antagonists with pancreatic enzymes

1993-01-01 Braga, Marco; Zerbi, Alessandro; Malesci, Alberto Carlo Piero; Dal Cin, Stefano; Valentini, Angela; Tacconi, Milena; Erenbourg, Luciano; Paganelli, Michele; Di Carlo, Valerio

RELIABILITY OF PANCREATIC-CANCER STAGING CLASSIFICATIONS

1994-01-01 Zerbi, A; Balzano, G; Bottura, R; Dicarlo, V

[Advances and perspectives in acute pancreatitis]. FT Novita e prospettive nella pancreatite acuta.

1995-01-01 Di Carlo, V; Zerbi, A

THE ROLE OF INTRAOPERATIVE THERAPY BY ELECTRON-BEAM AND COMBINATION OF ADJUVANT CHEMOTHERAPY AND EXTERNAL RADIOTHERAPY IN CARCINOMA OF THE PANCREAS

1995-01-01 Fossati, V; Cattaneo, Gm; Zerbi, A; Galli, L; Bordogna, G; Reni, M; Parolini, D; Carlucci, M; Bissi, A; Staudacher, C; Dicarlo, V; Calandrino, R

PANCREATIC-CARCINOMA - MR ASSESSMENT OF TUMOR INVASION OF THE PERIPANCREATIC VESSELS

1995-01-01 Sironi, S; Decobelli, F; Zerbi, A; Balzano, G; Dicarlo, V; Delmaschio, A

Intraoperative and postoperative radiotherapy in pancreatic cancer

1997-01-01 Dicarlo, V; Zerbi, A; Balzano, G; Villa, E

Accuracy of the plasma amino acid-consumption test in detecting pancreatic diseases is due to different methods

1999-01-01 Mariani, A; Mezzi, G; Masci, E; Soldarini, A; Calori, G; Zerbi, A; Tittobello, A

Titolo	Data di pubblicazione	Autore(i)
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.	1-gen-2009	Mantovani, A; Sica, A; Allavena, P; Garlanda, C; Locati, M.
Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.	1-gen-2010	Lech, M; Skuginna, V; Kulkarni, Op; Gong, J; Wei, T; Stark, Rw; Garlanda, C; Mantovani, A; Anders, Hj.
Serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and pentraxin 3 (PTX3) as markers of infection in febrile patients with systemic lupus erythematosus.	1-gen-2009	Kim, J; Koh, Jk; Lee, Ey; Park, Ja; Kim, Ha; Lee, Eb; Garlanda, C; Cotena, A; Song, Yw.
Evolution of the pentraxin family: the new entry PTX4.	1-gen-2010	Martinez de la Torre, Y; Fabbri, M; Jaillon, S; Bastone, A; Nebuloni, M; Vecchi, A; Mantovani, A; Garlanda, C
The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa.	1-gen-2011	Moalli, F; Paroni, M; Véliz Rodriguez, T; Riva, F; Polentarutti, N; Bottazzi, B; Valentino, S; Mantero, S; Nebuloni, M; Mantovani, A; Bragonzi, A; Garlanda, C
Pentraxins and atherosclerosis: the role of PTX3.	1-gen-2011	Garlanda, C; Bottazzi, B; Moalli, F; Deban, L; Molla, F; Latini, R; Mantovani, A
The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.	1-gen-2010	Norata, Gd; Garlanda, C; Catapano, Al
Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus.	1-gen-2011	Lech, M; Römmele, C; Kulkarni, Op; Susanti, He; Migliorini, A; Garlanda, C; Mantovani, A; Anders, Hj.
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials	1-gen-2012	Stefanini, G. G.; Byrne, R. A.; Serruys, P. W.; de Waha, A; Meier, B; Massberg, S; Jüni, P; Schömig, A; Windecker, S; Kastrati, A.
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques.	1-gen-2012	Räber, L; Heo, J. H.; Radu, M. D.; Garcia-Garcia, H. M.; Stefanini, G. G.; Moschovitis, A; Dijkstra, J; Kelbaek, H.; Windecker, S; Serruys, P. W.
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial	1-gen-2011	Stefanini, G. G.; Serruys, P. W.; Silber, S; Khattab, A. A.; van Geuns, R. J.; Richardt, G; Buszman, Pe; Kelbæk, H; van Boven, Aj; Hofma, S. H.; Linke, A; Klauss, V; Wijns, W; Macaya, C; Garot, P; Di Mario, C; Manoharan, G; Kornowski, R; Ischinger, T; Bartorelli, A. L.; Gobbens, P; Windecker, S.
A prospective study to evaluate the accuracy of pulse power analysis to monitor cardiac output in critically ill patients	1-gen-2008	Cecconi, M; Jayne, Fawcett; Robert Michael, Grounds; Andrew, Rhodes
Treatment strategy for colorectal cancer with resectable synchronous liver metastases: Is any evidence-based strategy possible?	1-gen-2012	Vigano', L
Fat-absorptiom and gastroenteric pH profile in postsurgical pancreatic insufficiency: Role of the association of H2-receptor antagonists with pancreatic enzymes	1-gen-1993	Braga, Marco; Zerbi, Alessandro; Malesci, Alberto Carlo Piero; Dal Cin, Stefano; Valentini, Angela; Tacconi, Milena; Erenbourg, Luciano; Paganelli, Michele; Di Carlo, Valerio
RELIABILITY OF PANCREATIC-CANCER STAGING CLASSIFICATIONS	1-gen-1994	Zerbi, A; Balzano, G; Bottura, R; Dicarlo, V
[Advances and perspectives in acute pancreatitis]. FT Novita e prospettive nella pancreatite acuta.	1-gen-1995	Di Carlo, V; Zerbi, A
THE ROLE OF INTRAOPERATIVE THERAPY BY ELECTRON-BEAM AND COMBINATION OF ADJUVANT CHEMOTHERAPY AND EXTERNAL RADIOTHERAPY IN CARCINOMA OF THE PANCREAS	1-gen-1995	Fossati, V; Cattaneo, Gm; Zerbi, A; Galli, L; Bordogna, G; Reni, M; Parolini, D; Carlucci, M; Bissi, A; Staudacher, C; Dicarlo, V; Calandrino, R
PANCREATIC-CARCINOMA - MR ASSESSMENT OF TUMOR INVASION OF THE PERIPANCREATIC VESSELS	1-gen-1995	Sironi, S; Decobelli, F; Zerbi, A; Balzano, G; Dicarlo, V; Delmaschio, A
Intraoperative and postoperative radiotherapy in pancreatic cancer	1-gen-1997	Dicarlo, V; Zerbi, A; Balzano, G; Villa, E
Accuracy of the plasma amino acid-consumption test in detecting pancreatic diseases is due to different methods	1-gen-1999	Mariani, A; Mezzi, G; Masci, E; Soldarini, A; Calori, G; Zerbi, A; Tittobello, A

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 24.481 a 24.500 di 27.856

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext25603
reserved1362
open891